# Impact of MIgalastat TheRApy on CaRdiac Function in patiEnts With Fabry's Cardiomyopathy (MIRACRE-Fabry Trial)

> **NCT04639999** · — · UNKNOWN · sponsor: **Yonsei University** · enrollment: 20 (estimated)

## Conditions studied

- Fabry Disease

## Interventions

- **OTHER:** Echocardiography

## Key facts

- **NCT ID:** NCT04639999
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-05
- **Primary completion:** 2025-01
- **Final completion:** 2025-04
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2021-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04639999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04639999, "Impact of MIgalastat TheRApy on CaRdiac Function in patiEnts With Fabry's Cardiomyopathy (MIRACRE-Fabry Trial)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04639999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*